Lozenge for the modified releasing of active substances in the gastrointestinal tract
AssigneeLTS Lohmann Therapie-Systeme AG
InventorKarsten Cremer
Life of this patent
Estimating the term…
Abstract
A pharmaceutical lozenge for the modified release of active compounds in the gastrointestinal tract is described, with active-compound-containing particles which have a first coating controlling the release and a further, outer coating with saliva-resistant properties. The first coating, which controls the release of active compound, can have release-delaying or enteric properties.
Claims9
Pharmaceutical lozenge pressed from pulverulent or granular press material wherein the press material contains an active-compound preparation in the form of at least two-layer coated particles in addition to customary auxiliaries suitable for the production of lozenges, an outer coating layer being saliva-resistant, but soluble in gastric juice, and an inner coating layer being largely disintegration resistant in aqueous media, but allowing a delayed release of active compound by diffusion, and wherein said lozenge erodes in the mouth upon oral administration, thus releasing said coated particles in finely divided form into the saliva.
A pharmaceutical presentation form for the modified release of active compounds into the (gastrointestinal tract comprising individually coated particles of said active compound, wherein the coating of said particles comprises a first inner coating layer which is capable to modify the release of said active compound in the gastrointestinal tract, and a second external coating layer which is resistant to saliva and soluble in the acidic medium of the stomach, said coated particles being released from said pharmaceutical presentation form upon sucking in the mouth, thereby being able to be swallowed with the saliva in finely divided form.
A process for the preparation of a pharmaceutical presentation form for the modified release of active compounds into the gastrointestinal trace comprising the steps:
- a) preparation of particles of said active compound,
- b) coating the particles of step a) into a spray application process with a first coating material that is capable to modify the release of said active Compound in the gastrointestinal tract,
- c) coating the particles of step b) in a spray application process with a second coating material that is resistant to saliva and soluble in the acidic medium of the stomach, and
- d) compressing the particles of step c) with auxiliary substances in a tablet machine.
Dependencies are inferred from the claim text.